Ubiquitin Drug Discovery & Diagnostics 2010, Philadelphia PA

The ubiquitin story continues to grow as more companies exploit this critical regulatory pathway for the discovery and development of therapeutics. Is it likely that the ubiquitome will replace the kinome as the most promising source of new medicines?
This conference will enable members of the academic,pharmaceutical, biotech and business communities to exchange ideas and listen to world experts in ubiquitin-based drug discovery, development, and diagnostics. Drug discovery advances and opportunities in oncology, infectious diseases, neurodegeneration, inflammation, diabetes, and muscle wasting will be covered.

Further Information: http://www.ubiquitinconference.com